Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly

Growth Hormone and IGF Research

Volumn 19, Issue 1, 2009, Pages 24-30

  Tanriverdi, F ^a   Yapislar, H ^a   Karaca, Z ^a   Unluhizarci, K ^a   Suer, C ^a   Kelestimur, F ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Acromegaly; Cognitive function; GH deficiency; Growth hormone; IGF I; P300 event related potentials; Quality of life

Indexed keywords

SOMATOMEDIN C;

ACROMEGALY; ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTRODE; EVOKED AUDITORY RESPONSE; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; LATENT PERIOD; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACROMEGALY; ADULT; COGNITION; COGNITION DISORDERS; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED;

EID: 58649090249     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.05.002     Document Type: Article

References (39)

1. Deijen J.B., de Boer H., Blok G.J., and van der Veen E.A. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 21 (1996) 313-322
2. Deijen J.B., de Boer H., and van der Veen E.A. Cognitive changes during growth hormone replacement in adult men. Psychoneuroendocrinology 23 (1998) 45-55
3. Sartorio A., Conti A., Molinari E., Riva G., Morabito F., and Faglia G. Growth, growth hormone and cognitive functions. Horm. Res. 45 (1996) 23-29
4. Tanriverdi F., Unluhizarci K., Kula M., Guven M., Bayram F., and Kelestimur F. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome. Growth Horm. IGF Res. 15 (2005) 231-237
5. Tanriverdi F., Unluhizarci K., and Kelestimur F. Growth hormone replacement therapy in adults with growth hormone deficiency: benefits and cost-effectiveness. Expert Rev. Pharmacoeconom. Outcomes Res. 6 (2006) 131-138
6. Burman P., and Deijen J.B. Quality of life and cognitive function in patients with pituitary insufficiency. Psychother. Psychosom. 67 (1998) 154-167
7. Falleti M.G., Maruff P., Burman P., and Harris A. The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature. Psychoneuroendocrinology 31 (2006) 681-691
8. van Dam P.S., Aleman A., de Vries W.R., Deijen J.B., van der Veen E.A., de Haan E.H., and Koppeschaar H.P. Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm. IGF Res. 10 Suppl. B (2000) 69-73
9. Han V.K. Is the central nervous system a target for growth hormone and insulin-like growth factors?. Acta Paediatr. 411 (1995) 3-8
10. Ransome M.I., Goldshmit Y., Bartlett P.F., Waters M.J., and Turnley A.M. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness. Eur. J. Neurosci. 19 (2004) 2069-2079
11. Sathiavageeswaran M., Burman P., Lawrence D., Harris A.G., Falleti M.G., Maruff P., and Wass J. Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study. Eur. J. Endocrinol. 156 (2007) 439-447
12. Rowles S.V., Prieto L., Badia X., Shalet S.M., Webb S.M., and Trainer P.J. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J. Clin. Endocrinol. Metab. 90 (2005) 3337-3341
13. Webb S.M., and Badia X. Quality of life in growth hormone deficiency and acromegaly. Endocrinol. Metab. Clin. N Am. 36 (2007) 221-232
14. Badia X., Webb S.M., Prieto L., and Lara N. Acromegaly quality of life questionnaire (AcroQoL). Health Qual. Life Outcomes 2 (2004) 13
15. Sutton S., Braren M., Zubin J., and John E.R. Evoked-potential correlates of stimulus uncertainty. Science 150 (1965) 1187-1188
16. Ortiz A.T., Perez-Serrano J.M., Zaglul Z.C., Coullaut G.J., Coullaut G.R., and Criado R.J. P300 clinical utility in major depression. Actas Esp. Psiquiatr. 30 (2002) 1-6
17. Wright M.J., Hansell N.K., Geffen G.M., Geffen L.B., Smith G.A., and Martin N.G. Genetic influence on the variance in P3 amplitude and latency. Behav. Genet. 31 (2001) 555-565
18. Goodin D., Desmedt J., Maurer K., and Nuwer M.R. IFCN recommended standards for long-latency auditory event-related potentials. Report of an IFCN committee. International federation of clinical neurophysiology. Electroencephalogr. Clin. Neurophysiol. 91 (1994) 18-20
19. Polich J., and Herbst K.L. P300 as a clinical assay: rationale, evaluation, and findings. Int. J. Psychophysiol. 38 (2000) 3-19
20. Verleger R. On the utility of P3 latency as an index of mental chronometry. Psychophysiology 34 (1997) 131-156
21. Gironell A., Garcia-Sanchez C., Estevez-Gonzalez A., Boltes A., and Kulisevsky J. Usefulness of p300 in subjective memory complaints: a prospective study. J. Clin. Neurophysiol. 22 (2005) 279-284
22. Golgeli A., Tanriverdi F., Suer C., Gokce C., Ozesmi C., Bayram F., and Kelestimur F. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehan's syndrome and effects of GH replacement therapy. Eur. J. Endocrinol. 150 (2004) 153-159
23. Kelestimur F. Sheehan's syndrome. Pituitary 6 (2003) 181-188
24. Golgeli A., Suer C., Ozesmi C., Dolu N., Ascioglu M., and Sahin O. The effect of sex differences on event-related potentials in young adults. Int. J. Neurosci. 99 (1999) 69-77
25. Burman P., Broman J.E., Hetta J., Wiklund I., Erfurth E.M., Hagg E., and Karlsson F.A. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J. Clin. Endocrinol. Metab. 80 (1995) 3585-3590
26. Sartorio A., Molinari E., Riva G., Conti A., Morabito F., and Faglia G. Growth hormone treatment in adults with childhood onset growth hormone deficiency: effects on psychological capabilities. Horm. Res. 44 (1995) 6-11
27. Triantafyllou N.I., Aivalis N., Alexopoulos S., Romessis N., Gerontas A., Stavropoulos P., Sfagos C., Athanassopoulou A., Gouliamos A., and Papageorgiou C. Cognitive function in non-demented individuals complaining of short-term memory disturbances: a study with event-related potentials (P300) and brain CT scan. Electromyogr. Clin. Neurophysiol. 37 (1997) 317-320
28. Anderer P., Semlitsch H.V., Saletu B., Saletu-Zyhlarz G., Gruber D., Metka M., Huber J., Graser T., and Oettel M. Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. Psychoneuroendocrinology 28 (2003) 419-445
29. Braverman E.R., and Blum K. P300 (latency) event-related potential: an accurate predictor of memory impairment. Clin. Electroencephalogr. 34 (2003) 124-139
30. Kinoshita S., Inoue M., Maeda H., Nakamura J., and Morita K. Long-term patterns of change in ERPs across repeated measurements. Physiol. Behav. 60 (1996) 1087-1092
31. Neshige R., Barrett G., and Shibasaki H. Auditory long latency event-related potentials in Alzheimer's disease and multi-infarct dementia. J. Neurol. Neurosurg. Psychiatry 51 (1988) 1120-1125
32. Naganuma Y., Konishi T., Matsui M., Hongou K., Murakami M., Yamatani M., and Okada T. The relationship between P300 latencies, and WISC-R and Wechsler memory scale results in epileptic children. No To Hattatsu 25 (1993) 515-520
33. Magliero A., Bashore T.R., Coles M.G., and Donchin E. On the dependence of P300 latency on stimulus evaluation processes. Psychophysiology 21 (1984) 171-186
34. Dostalova S., Sonka K., Smahel Z., Weiss V., and Marek J. Cephalometric assessment of cranial abnormalities in patients with acromegaly. J. Craniomaxillofac. Surg. 31 (2003) 80-87
35. Frodl T., Meisenzahl E.M., Muller D., Leinsinger G., Juckel G., Hahn K., Moller H.J., and Hegerl U. The effect of the skull on event-related P300. Clin. Neurophysiol. 112 (2001) 1773-1776
36. Creyghton W.M., van Dam P.S., and Koppeschaar H.P. The role of the somatotropic system in cognition and other cerebral functions. Semin. Vasc. Med. 4 (2004) 167-172
37. Oken B.S. Endogenous event-related potentials. In: Chiappa K.H. (Ed). Evoked Potentials in Clinical Medicine (1997), JB Lippincott Company, Philadelphia 529-563
38. Frodl-Bauch T., Bottlender R., and Hegerl U. Neurochemical substrates and neuroanatomical generators of the event-related P300. Neuropsychobiology 40 (1999) 86-94
39. Meador K.J., Loring D.W., Davis H.C., Sethi K.D., Patel B.R., Adams R.J., and Hammond E.J. Cholinergic and serotonergic effects on the P3 potential and recent memory. J. Clin. Exp. Neuropsychol. 11 (1989) 252-260